Mizuho Securities analyst Uy Ear has maintained their neutral stance on RVNC stock, giving a Hold rating on November 11. Uy Ear’s rating ...
Werewolf Therapeutics ( (HOWL) ) just unveiled an update. Werewolf Therapeutics is pioneering the development of innovative cytokine therapies ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback